Cervical Cancer-Free America Initiative Overview Changing the Dialogue about Cervical Cancer Prevention Jennifer S. Smith University of North Carolina JenniferS@unc.edu Carolina Framework for Action against Cervical Cancer There are four key challenges to eradication of cervical cancer that a comprehensive public health strategy can address: • • • • HPV infection Lack of screening Screening errors Not receiving follow-up care for abnormal Pap smear results Brewer and Smith HPV virus-like particles (VLPs): Basis of HPV vaccination For Prevention of Cervical Cancer: • Persistent HPV 16/18 infections • HPV 16/18 abnormal pap smear HPV Type Specific Prevalence in All Cases HPV Types by Cervical Status: Potential Impact of 16/18 Vaccine 100% 80% 60% 40% ~70% ~50% 20% ~14-25% 0% Invasive Cancer HSIL ICC data: Smith et al. Int Journal of Cancer, 2007, 121 (3), 621-32. HSIL data: Smith et al. Int Journal of Cancer, 2007, 121 (3), 621-32. LSIL data: Clifford et al. Cancer Epidemiol Biomarkers. 2005;14:1157-1164 LSIL Optimal to Vaccinate Adolescent Girls before Sexual Debut 35 % Estimated start of sexual life 30 25 Frequency Papillomavirus 20 Infection (all types) 15 10 5 0 5 10 15 20 25 30 35 40 45 50 Age (years) 1- Hypothetical distribution of HPV prevalence in EU modeled after data available in the US and Canada 55 60 65 70 75 Prophylactic HPV Vaccine Approved for Adolescent Girls Vaccine HPV Types FDA approved Age range Bivalent 16/18 2009 10-25* yrs Quadrivalent 6/11/16/18 2006 9-26* yrs *Routine vaccination for 11-12 year old females HPV Vaccine Coverage National Immunization Survey-Teen Females aged 13-17 years US 2009: 44.3% (42.4%-46.1%) for 1+ dose 26.7% (25.2%-28.3%) for 3 doses completed August 20, 2010 / 59(32);1018-1023 HPV Type Specific Prevalence in All Cases Continued Need for Screening Following HPV Vaccination 100% 80% 60% 40% ~70% ~50% 20% ~14-25% 0% Invasive Cancer HSIL ICC data: Smith et al. Int Journal of Cancer, 2007, 121 (3), 621-32. HSIL data: Smith et al. Int Journal of Cancer, 2007, 121 (3), 621-32. LSIL data: Clifford et al. Cancer Epidemiol Biomarkers. 2005;14:1157-1164 LSIL Decrease in Cervical Cancer Mortality Following Introduction of Pap Test in the United States Number of Deaths 30,000 25,000 20,000 15,000 10,000 5,000 0 1941 1995 1999 2003 Years 2006 2009 1. OBGYN.net. Available at: http://www.obgyn.net/displayarticle.asp?page=/yw/articles/braun_PAP 2. American Cancer Society. Cancer Facts & Figures. Available at: http://www.cancer.org/ Sensitivity of Cervical Cancer Screening Methods Endpoint ≥CIN 2 Screening method Sensitivity % (95% CI) Pap smear only 71 (61-81) HPV DNA test only 95 (89-99) Pap smear with HPV DNA test 100 (96-100) Naucler P, et al. JNCI. 2009;101:88-99. Pap Smear Guidelines: 2009 American College of Obstetrics and Gynecology <21 Years No routine Pap smear *History 21-29 Years Bi-annual Pap smear of cervical cancer or DES in utero, HIV positive, immunosuppression, or other risk factors for acquiring STDs. 30-64 Years Pap smear every 3 years ..if patient has had 3 or more normal Pap results in a row, no abnormal test results in 10 years, and lacks other risk factors.* ≥65 Years Consider discontinuing Pap smear at 65 or 70 years ..if patient has had 3 or more normal Pap results in a row, no abnormal test results in 10 years, and lacks other risk factors.* ACOG Practice Bulletin No. 109. Obstet Gynecol. 2009;114:1409-20. We can Change the Dialogue We can End Cervical Cancer Policy Makers Vaccination Screening We can Effect Real Change at the State-Level Age-adjusted Mortality Rates per 100,000, 2001-2005 SEER Data Indiana Kentucky California DC North Carolina Age-adjusted Death Rates per 100,000 Quantile Interval 3.0 – 3.7 2.8 – 2.9 2.5 – 2.7 Alabama HAWAII ALASKA Texas SEER = Surveillance, Epidemiology, and End Results 2.2 – 2.4 1.9 – 2.1 1.5 – 1.8 US Rate 2.5 1. Surveillance, Epidemiology and End Results (SEER) Cancer Stats NCI, 2001-2005. Cervical Cancer Free America Common State Goals To increase HPV vaccination among young female adolescents ages 10-18 To increase cervical cancer screening among women ages 25-70 who have not been screened in the last four years . Cervical Cancer Free California California Medical Association Foundation Sara Cook, Carol Lee, Elissa Maas Cervical Cancer Free Alabama University of Alabama Mona Fouad, Warner Huh, Theresa Wynn Cervical Cancer Free Kentucky University of Kentucky Baretta Casey, Rick Crosby, Robin Vanderpool Cervical Cancer Free Indiana University of Indiana Gregory Zimet Kirk Forbes Cervical Cancer Free North Carolina University of North Carolina Noel Brewer, Pamela Entzel, Jennifer Smith How Can We Work Actively Together? January: Cervical Cancer Awareness Month is right around the corner.